• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

SMG 1465.7

FDA STAFF MANUAL GUIDES, VOLUME II - DELEGATIONS OF AUTHORITY

ADMINISTRATIVE – FINANCIAL MANAGEMENT

AUTHORITY TO COMPROMISE, TERMINATE, OR SUSPEND COLLECTION OF CLAIMS UNDER THE FEDERAL CLAIMS COLLECTIONS ACT

Effective Date: 01/08/2010

[PDF Version]

1. AUTHORITY DELEGATED.

To compromise or terminate debts or to suspend collection of claims of $100,000 or less, exclusive of interest, under the Federal Claims Collection Act, as amended (31 U.S.C. 3711), insofar as such authority relates to the activities of the Food and Drug Administration.

For claims greater than $100,000, the authority to compromise, terminate or suspend claims rests with the Department of Justice.

2. TO WHOM DELEGATED.

A. Director, Office of Financial Management (OFM), Office of Financial Operations (OFO).

B. Director, Division of Accounting, OFM, OFO.

All previous delegations of authority inconsistent with the provisions of this delegation are superseded.

3. LIMITATIONS.

Prior to termination of claims, FDA and FDA’s debt collection agency (PSC) will exhaust all avenues of collection including the Department of Justice and Department of Treasury Off-set Programs.

4. REDELEGATION AND CERTIFICATION.

These authorities may not be further redelegated.

5. EFFECTIVE DATE.

Russell J. Abbott, Deputy Commissioner for Administration, approved this delegation, via memorandum, on January 8, 2010.

STATUS (I, R, C)DATE APPROVEDLOCATION OF CHANGE HISTORYCONTACTAPPROVING OFFICIAL
Initial09/16/2008N/aOC/OM/OMPJohn P. Gentile, Associate Commissioner for Operations
Revised01/08/2010N/aOC/OA/OFOR. Abbott, Deputy Commissioner for Administration